Results 231 to 240 of about 143,820 (254)

Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies. [PDF]

Semin Hematol
Weeks LD.
europepmc   +1 more source

Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review [PDF]

Journal of Clinical Medicine, 2020
Some random mutations can confer a selective advantage to a hematopoietic stem cell. As a result, mutated hematopoietic stem cells can give rise to a significant proportion of mutated clones of blood cells.
Paola Rizzo, Luisa Marracino, Gianluca Campo   +2 more
exaly   +3 more sources

Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss [PDF]

Cell
Clonal hematopoiesis of indeterminate potential (CHIP) arises from aging-associated acquired mutations in hematopoietic progenitors, which display clonal expansion and produce phenotypically altered leukocytes.
George Hajishengallis
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis

Cell, 2021
Martin A. Nowak, Shuang Zhang, Kamila Naxerova   +2 more
exaly  

Clonal hematopoiesis, somatic mosaicism, and age-associated disease

Physiological Reviews, 2023
Kenneth Walsh
exaly  

Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population

Cancer Cell, 2023
Ilja M Nolte, Bert A van der Reijden, Jan Jacob Schuringa   +2 more
exaly  

Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling

Cell Stem Cell, 2021
Marek Kimmel, Pawel Kus, Katherine Y King   +2 more
exaly